AstraZeneca PLC warned earnings would fall this year as it continues to plow investment into research and development and expects a sharp drop in sales for one of its blockbuster drugs, surprising investors and sending shares down more than 4% in early trading here.
from WSJ.com: US Business http://ift.tt/1PC8qbG
via IFTTT
No comments:
Post a Comment